Skip Main Navigation
Page Content

Save This Event

Event Saved

[NYC Session] Meet With... NCI and NIAID SBIR Programs

Johnson & Johnson Innovation, JLABS

Thursday, September 14, 2017 from 9:00 AM to 12:30 PM (EDT)

[NYC Session] Meet With... NCI and NIAID SBIR Programs

Ticket Information

Ticket Type Sales End Price Fee Quantity
General Public   more info Sep 13, 2017 $25.00 $2.37
Media/Press   more info Sep 4, 2017 Free $0.00
Volunteer   more info Aug 31, 2017 Free $0.00
At the Door - Presentation & Lunch Only Not Started $35.00 $2.92

Share [NYC Session] Meet With... NCI and NIAID SBIR Programs

Event Details

The National Cancer Institute (NCI) and the National Institute of Allergy and Infectious Diseases (NIAID) are coming to JLABS @ NYC! On September 14, program directors Todd Haim with NCI, Natalia Kruchinin and Mike Minnicozzi with NIAID, will be presenting funding opportunities and other resources for startups in cancer technology and in allergy, immunology and infectious diseases.

You will learn about 15 new targeted funding opportunities in cancer detection, diagnosis, and treatment in high priority areas of research for the NCI. Although the trends reflect improvements in cancer treatments, and advances in technology have led to better tools for understanding, detecting, and diagnosing cancer – we still have work to do. In 2017, an estimated 1,688,780 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.

Additionally, high priority research areas of interest for NIAID investigator-initiated research as well as targeted opportunities will be discussed. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic and allergic diseases. NIAID has a unique mandate requiring the Institute to respond to emerging public health threats within the US and abroad. Its research portfolio includes a diverse selection across research in three key mission areas: 1) HIV/AIDS, 2) Allergy, Immunology and Transplantation, and 3) Microbiology and Infectious Diseases.

Program Overview:
NCI and NIAID PRESENT CURRENT AND NEW FUNDING OPPORTUNITIES
Program directors will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development as well as allergy, immunology and infectious disease. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will review the I-Corps at NIH program, and other initiatives run by NCI and/or NIAID to facilitate the success of SBIR companies.

Additionally, high priority research areas of interest for NIAID investigator-initiated research as well as targeted opportunities will be discussed. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic and allergic diseases. NIAID has a unique mandate requiring the Institute to respond to emerging public health threats within the US and abroad. Its research portfolio includes a diverse selection across research in three key mission areas: 1) HIV/AIDS, 2) Allergy, Immunology and Transplantation, and 3) Microbiology and Infectious Diseases.

Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI or NIAID. Applications were due August 22. Missed the application deadline for a one-on-one meeting? Please contact Samantha Lifson (slifson@its.jnj.com) with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with either the NCI or NIAID.


Speakers:
Todd Haim | Program Director, SBIR Development Center, National Cancer Institute read bio»
Natalia Kruchinin | Small Business Program Coordinator, National Institute of Allergy and Infectious Diseases read bio»
Mike Minnicozzi | Program Officer, National Institute of Allergy and Infectious Diseases read bio»


Agenda:
9:00 AM | Registration Opens
9:30 AM | Presentation and Q&A
                 - Overview of the NIH SBIR/STTR Program
                 - NCI SBIR Initiatives and Tips on Submitting Competitive Applications
                 - Understanding NIAID’s Mission and SBIR/STTR Research Priorities
                 - Q&A
11:15 AM | Networking Lunch
12:30-3:00 PM | One-on-One Meetings


Fees:
Presentation
$25 | General Public
$35 | At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on September 13th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Applications were due August 22. Missed the application deadline for a one-on-one meeting? Please contact Samantha Lifson (slifson@its.jnj.com) with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with either the NCI or NIAID.


Speakers' Biographies:

Todd Haim, Ph.D. | Program Director, SBIR Development Center, National Cancer Institute
Dr. Todd Haim is a Program Director at the National Cancer Institute's SBIR Development Center. Dr. Haim manages SBIR & STTR grants and contracts focused on the development of novel cancer therapeutics and drug discovery technologies that incorporate the tumor microenvironment. Additionally, Todd plays a key role in the planning, design, and leadership of several center initiatives, including serving as coordinator of NCI Investor Initiatives, helping to implement relevant workshops, draft targeted solicitations, and facilitate external partnerships. Prior to starting in the SBIR Development Center, he was a Research Associate and Christine Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences. Dr. Haim staffed the Committee on Science, Engineering and Public Policy (COSEPUP) and his efforts centered on follow-up activities to the 2005 "Rising Above the Gathering Storm" report related to various innovation initiatives and evaluation programs. Previously, he completed a postdoctoral fellowship at Pfizer in which he actively led Pfizer's research efforts in a collaboration with Washington University School of Medicine in St. Louis that illustrated a mechanism for altered cardiac contractility due to excess fatty acids. Dr. Haim graduated from Albert Einstein College of Medicine in January 2007 with a PhD in biomedical research and obtained a certificate in technology commercialization from John Hopkins' Carey Business School in 2011. He has received several prestigious awards and honors including the 2014 NCI Leadership Development Award, multiple NIH and NCI Director's Awards and the NJ Governor's Award for Volunteerism in the Field of Health.



Natalia Kruchinin, Ph.D. | Small Business Program Coordinator, National Institute of Allergy and Infectious Diseases
Dr. Kruchinin is a Small Business Program Coordinator at National Institute of Allergy and Infectious Diseases (NIAID) NIH. In her current position, Dr. Kruchinin serves as the program director of the NIAID Small Business Center and a senior program leader and advisor to the director of Office of Research Training and Special Programs (ORTSP) and to the Director of the Division of Extramural Activities (DEA) and provide leadership, coordination, and oversight of a broad range of scientific and managerial activities and processes within the NIAID. Prior to NIAID Dr. Kruchinin served as a Program Director with the SBIR Development Center at the National Cancer Institute, NIH. There, she assisted hundreds of small businesses in the Cancer Diagnostics & Therapeutics field in securing government funding for innovative research and development projects with high commercial potential.
Dr. Kruchinin has formal training and work experience in several cross-cutting science areas. Her research experience covers university, biotechnology industry, and government settings. Before joining NIAID and NCI, she held positions as a manager of the Molecular Diagnostics Application lab at QIAGEN Inc., senior scientist at Motorola Life Sciences and research scientist at Oak Ridge National Laboratory, TN.
Dr. Kruchinin holds a Ph.D. in molecular biology from Saint Petersburg State University, Russia.



Mike Minnicozzi, Ph.D. | Program Officer, National Institute of Allergy and Infectious Diseases
Dr. Minnicozzi joined the NIAID's Division of Allergy, Inflammation and Transplantation in October 2005 as a Program Officer. He received his doctoral degree in physiology from the University of Medicine and Dentistry of New Jersey. Prior to joining the Division, he was a Principal Research Scientist at the Schering Plough Research Institute in Kenilworth NJ. Mike has over 25 years of preclinical and clinical pharmaceutical research experience and several years of experience in business development. His scientific interests cover; pulmonary inflammation and physiology, epithelial cell biology, animal models of human disease and pharmacology. In addition to his employment at SPRI, Dr. Minnicozzi also served on the Northeast Peer Review Consortium of the American Heart Association and was an Adjunct Professor at UMDNJ. Most recently, Mike has taken over the NIAID-DAIT portfolio of SBIR awards and is responsible for programmatic and scientific stewardship of these applications.




About the Meet With... Series:
The purpose of the Meet with series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, OrbiMed, Osage University Partners, Spectrum 28, Quark Venture, and AbbVie Ventures.


Venue:
New York Genome Center
101 6th Ave, 1st floor
New York, NY 10013

Have questions about [NYC Session] Meet With... NCI and NIAID SBIR Programs? Contact Johnson & Johnson Innovation, JLABS

Save This Event

Event Saved

When & Where


New York Genome Center
101 6th Ave, 1st floor
New York, NY 10013

Thursday, September 14, 2017 from 9:00 AM to 12:30 PM (EDT)


  Add to my calendar

Organizer

Johnson & Johnson Innovation, JLABS

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
[NYC Session] Meet With... NCI and NIAID SBIR Programs
Things to do in New York, NY Class Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.